Cite
MLA Citation
F.S. Macaluso et al.. “OC.10.3 THE EFFECTIVENESS OF USTEKINUMAB AND VEDOLIZUMAB AS THIRD-LINE THERAPY IN PATIENTS WITH REFRACTORY CROHN'S DISEASE.” Digestive and liver disease, vol. 54, n.d., pp. S93–S94. http://access.bl.uk/ark:/81055/vdc_100154241872.0x00001c